Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of lipid components in lipid nanoparticles for vaccines and gene therapy
Camilla Hald Albertsen, Jayesh A. Kulkarni, Dominik Witzigmann, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114416-114416
Open Access | Times Cited: 523

Showing 1-25 of 523 citing articles:

A Comprehensive Review of mRNA Vaccines
Vrinda Gote, Pradeep Kumar Bolla, Nagavendra Kommineni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2700-2700
Open Access | Times Cited: 178
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 105
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
Bioconjugate Chemistry (2023) Vol. 34, Iss. 6, pp. 941-960
Open Access | Times Cited: 87
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Michaela Jeong, Yeji Lee, Jeongeun Park, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114990-114990
Closed Access | Times Cited: 84
Current research trends of nanomedicines
Qiuyue Liu, Jiahui Zou, Zhongjian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4391-4416
Open Access | Times Cited: 70
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 64
Lipid nanoparticles for siRNA delivery in cancer treatment
Souhaila H. El Moukhtari, Elisa Garbayo, Ane Amundarain, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 130-146
Closed Access | Times Cited: 60
Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures
Sofie Meulewaeter, Gust Nuytten, Miffy H. Y. Cheng, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 149-160
Open Access | Times Cited: 59
mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 46
Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid
Yaru Jia, Xiu‐Guang Wang, Luwei Li, et al.
Advanced Materials (2023) Vol. 36, Iss. 4
Closed Access | Times Cited: 46
Aptamer-Based Targeted Protein Degradation
Yuan Liu, Xu Qian, Chunyan Ran, et al.
ACS Nano (2023) Vol. 17, Iss. 7, pp. 6150-6164
Open Access | Times Cited: 44
Insights into the Structure of Comirnaty Covid-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA–Lipid Complexes
János Szebeni, Bálint Kiss, Tamás Bozó, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13147-13157
Open Access | Times Cited: 41
Chemically Modified Platforms for Better RNA Therapeutics
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 39
Sustainable Nanomaterials for Biomedical Applications
Yuhang Zhang, Kingsley Poon, Gweneth Sofia P. Masonsong, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 922-922
Open Access | Times Cited: 38
The immunostimulatory nature of mRNA lipid nanoparticles
Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115175-115175
Open Access | Times Cited: 34
Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation
Kexin Su, Lu Shi, Tao Sheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives
Eliana B. Souto, Cristina Blanco-Llamero, Karolline Krambeck, et al.
Acta Biomaterialia (2024) Vol. 180, pp. 1-17
Open Access | Times Cited: 26
Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment
Changhong Zhao, Xinshu Zhu, Jianmei Tan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116113-116113
Open Access | Times Cited: 25
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 20
mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
Mariona Estapé Sentí, Lucía García del Valle, Raymond M. Schiffelers
Advanced Drug Delivery Reviews (2024) Vol. 206, pp. 115190-115190
Open Access | Times Cited: 19
Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease
Andrea Caporali, Maryam Anwar, Yvan Devaux, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 8, pp. 556-573
Closed Access | Times Cited: 17
Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 17
Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications
Д. Маникандан, Wei Wang, S.U. Mohammed Riyaz, et al.
3 Biotech (2024) Vol. 14, Iss. 2
Closed Access | Times Cited: 15
A perspective of lipid nanoparticles for RNA delivery
Yutian Ma, Shiyao Li, Xin Lin, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 15
AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery
Yue Xu, Shihao Ma, Haotian Cui, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top